Key Record Dates
ClinicalTrials.gov Identifier: | NCT02864381 |
---|---|
Brief Title: | Study to Evaluate the Efficacy and Safety of Andecaliximab Combined With Nivolumab Versus Nivolumab Alone in Adults With Unresectable or Recurrent Gastric or Gastroesophageal Junction Adenocarcinoma |
First Submitted : | August 10, 2016 |
First Submitted that Met QC Criteria : | August 10, 2016 |
First Posted : | August 12, 2016 (Estimate) |
Results First Submitted : | August 18, 2020 |
Results First Submitted that Met QC Criteria : | September 17, 2020 |
Results First Posted : | September 18, 2020 |
Certification/Extension First Submitted : | November 1, 2018 |
Certification/Extension First Submitted that Met QC Criteria : | November 1, 2018 |
Certification/Extension First Posted : | November 5, 2018 |
Last Update Submitted that Met QC Criteria : | September 17, 2020 |
Last Update Posted : | September 18, 2020 |